Identification of FABP7 as a Potential Biomarker for Predicting Prognosis and Antiangiogenic Drug Efficacy of Glioma

Figure 3

The relationship between FABP7 and prognosis of glioma patients by bioinformatics analysis based on the CGGA dataset and TCGA dataset and independent prognostic analysis and development of nomogram based on the CGGA dataset. Survival analysis in the high FABP7 and low FABP7 groups in glioma patients. (a) Based on the CGGA dataset (). (b) Based on the CGGA mRNAseq_301 dataset (). (c) Based on the TCGA dataset (). The ROC curve of FABP7. (d) Based on the CGGA dataset (). (e) Based on CGGA mRNAseq_301 dataset (). (f) Based on the TCGA dataset. (). Figure 4 (). (g) Univariate analysis of FABP7. (h) Multivariate analysis of FABP7. (i) Prognostic nomogram to predict the survival of glioma patients. (j–l) Nomogram calibration curves for predicting survival at 1, 2, and 3 years in the CGGA training cohort.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)

(k)

(l)